11-32434980-G-C

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_StrongBP6BP7BS1BS2_Supporting

The NM_024426.6(WT1):​c.381C>G​(p.Pro127Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000764 in 1,518,646 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. P127P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000085 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000075 ( 0 hom. )

Consequence

WT1
NM_024426.6 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:7

Conservation

PhyloP100: -0.720

Publications

0 publications found
Variant links:
Genes affected
WT1 (HGNC:12796): (WT1 transcription factor) This gene encodes a transcription factor that contains four zinc-finger motifs at the C-terminus and a proline/glutamine-rich DNA-binding domain at the N-terminus. It has an essential role in the normal development of the urogenital system, and it is mutated in a small subset of patients with Wilms tumor. This gene exhibits complex tissue-specific and polymorphic imprinting pattern, with biallelic, and monoallelic expression from the maternal and paternal alleles in different tissues. Multiple transcript variants have been described. In several variants, there is evidence for the use of a non-AUG (CUG) translation initiation codon upstream of, and in-frame with the first AUG. Authors of PMID:7926762 also provide evidence that WT1 mRNA undergoes RNA editing in human and rat, and that this process is tissue-restricted and developmentally regulated. [provided by RefSeq, Mar 2015]
WT1 Gene-Disease associations (from GenCC):
  • Denys-Drash syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, G2P
  • Wilms tumor 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • familial idiopathic steroid-resistant nephrotic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Frasier syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BP6
Variant 11-32434980-G-C is Benign according to our data. Variant chr11-32434980-G-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 261711.
BP7
Synonymous conserved (PhyloP=-0.72 with no splicing effect.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.0000754 (103/1366534) while in subpopulation MID AF = 0.0053 (21/3966). AF 95% confidence interval is 0.00355. There are 0 homozygotes in GnomAdExome4. There are 54 alleles in the male GnomAdExome4 subpopulation. Median coverage is 41. This position passed quality control check.
BS2
High AC in GnomAd4 at 13 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_024426.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
WT1
NM_024426.6
MANE Select
c.381C>Gp.Pro127Pro
synonymous
Exon 1 of 10NP_077744.4
WT1
NM_024424.5
c.381C>Gp.Pro127Pro
synonymous
Exon 1 of 10NP_077742.3H0Y7K5
WT1
NM_001407044.1
c.381C>Gp.Pro127Pro
synonymous
Exon 1 of 10NP_001393973.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
WT1
ENST00000452863.10
TSL:1 MANE Select
c.381C>Gp.Pro127Pro
synonymous
Exon 1 of 10ENSP00000415516.5P19544-7
WT1
ENST00000639563.4
TSL:1
c.381C>Gp.Pro127Pro
synonymous
Exon 1 of 9ENSP00000492269.3P19544-8
WT1
ENST00000332351.9
TSL:1
c.381C>Gp.Pro127Pro
synonymous
Exon 1 of 9ENSP00000331327.5J3KNN9

Frequencies

GnomAD3 genomes
AF:
0.0000855
AC:
13
AN:
152004
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00955
Gnomad NFE
AF:
0.0000883
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.0000879
AC:
10
AN:
113730
AF XY:
0.0000638
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000101
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000898
Gnomad OTH exome
AF:
0.000874
GnomAD4 exome
AF:
0.0000754
AC:
103
AN:
1366534
Hom.:
0
Cov.:
41
AF XY:
0.0000801
AC XY:
54
AN XY:
673944
show subpopulations
African (AFR)
AF:
0.000197
AC:
6
AN:
30400
American (AMR)
AF:
0.0000646
AC:
2
AN:
30962
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23502
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35848
South Asian (SAS)
AF:
0.0000527
AC:
4
AN:
75938
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
36594
Middle Eastern (MID)
AF:
0.00530
AC:
21
AN:
3966
European-Non Finnish (NFE)
AF:
0.0000513
AC:
55
AN:
1072506
Other (OTH)
AF:
0.000264
AC:
15
AN:
56818
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
7
14
21
28
35
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000855
AC:
13
AN:
152112
Hom.:
0
Cov.:
33
AF XY:
0.0000672
AC XY:
5
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41554
American (AMR)
AF:
0.000196
AC:
3
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5116
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10576
Middle Eastern (MID)
AF:
0.0103
AC:
3
AN:
292
European-Non Finnish (NFE)
AF:
0.0000883
AC:
6
AN:
67954
Other (OTH)
AF:
0.000474
AC:
1
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.529
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000218
Hom.:
0
Bravo
AF:
0.0000756

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
-
1
11p partial monosomy syndrome;C0950121:Drash syndrome;C0950122:Frasier syndrome;CN033288:Wilms tumor 1 (1)
-
-
1
Hereditary cancer-predisposing syndrome (1)
-
-
1
Inborn genetic diseases (1)
-
1
-
Meacham syndrome (1)
-
1
-
Nephrotic syndrome, type 4 (1)
-
-
1
not provided (1)
-
1
-
Wilms tumor 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.65
CADD
Benign
6.7
DANN
Benign
0.57
PhyloP100
-0.72
PromoterAI
0.0020
Neutral

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs771681406; hg19: chr11-32456526; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.